Profiel
Pernilla Abrahamsson is the founder of MD Biomedical AB. She is currently the Chief Operating Officer at Lipum AB. Previously, she worked as Manager-Product Development at Senzime AB from 2018 to 2019.
Dr. Abrahamsson obtained a doctorate degree from Umea Universitet.
Actieve functies van Pernilla Abrahamsson
| Bedrijven | Functie | Begin |
|---|---|---|
| LIPUM AB | Operationeel Directeur | 01-01-2019 |
Eerdere bekende functies van Pernilla Abrahamsson
| Bedrijven | Functie | Einde |
|---|---|---|
| SENZIME AB | Corporate Officer/Principal | 01-04-2019 |
MD Biomedical AB
MD Biomedical AB Medical/Nursing ServicesHealth Services Provides micro dialysis products and services | Oprichter | - |
Opleiding van Pernilla Abrahamsson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Senzime AB
Senzime AB Medical SpecialtiesHealth Technology Develops and markets an enzyme based biosensor technology | Health Technology |
Umea Universitet
Umea Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MD Biomedical AB
MD Biomedical AB Medical/Nursing ServicesHealth Services Provides micro dialysis products and services | Health Services |
Lipum AB
Lipum AB BiotechnologyHealth Technology Develops biological anti-inflammatory drugs | Health Technology |
















